Magazine
ENEWS
SUBSCRIBE
WEBINARS
PODCASTS
EBOOKS
Edit submissions
Press releases
Media kit
Innovation Awards
Industry News
Boehringer's Gilotrif Gets FDA Approval for NSCLC
July 16, 2013
Boehringer Ingelheim announces approval of its first oncology drug after regulators in the USA gave the green light to Gilotrif for late-stage non-small cell lung cancer. Read the
full story
Latest from Industry News
Pfizer to let go of 791 employees at NJ site
Novartis completes Sandoz spin-off
Gritstone wins BARDA bid for next-gen COVID vax
Kinnate to let go of 70% of employees
Load More Content